@article{6bae34632c904772991d3daeeb75614d,
title = "Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years{\textquoteright} follow-up",
abstract = "Trial registration: ClinicalTrials.gov",
author = "Eva Domingo-Dom{\`e}nech and Barbara Pro and Tim Illidge and Steven Horwitz and Lorenz Trumper and Swami Iyer and Ranjana Advani and Bartlett, \{Nancy L.\} and Christensen, \{Jacob Haaber\} and Kim, \{Won Seog\} and Tatyana Feldman and Ilseung Choi and Giuseppe Gritti and David Belada and Andrei Shustov and Arpad Illes and Zinzani, \{Pier Luigi\} and Andreas H{\"u}ttmann and Marek Trneny and \{Le Gouill\}, Steven and Deepa Jagadeesh and Friedberg, \{Jonathan W.\} and Meredith Little and Cassie Dong and Michelle Fanale and Keenan Fenton and Savage, \{Kerry J.\}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",
year = "2025",
month = dec,
doi = "10.1038/s41408-025-01329-2",
language = "English",
volume = "15",
journal = "Blood cancer journal",
issn = "2044-5385",
number = "1",
}